Chi Sheng Pharma & Biotech Co (ROCO:4111) Tariff Resilience Score: 0/10 (As of Jul. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4111 Chi Sheng Pharma & Biotech Co Ltd ROCO:4111
84 GF Score
Price NT$30.05
GF Value NT$33.16
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Chi Sheng Pharma & Biotech Co Tariff Resilience Score?

Chi Sheng Pharma & Biotech Co has the Tariff Resilience Score of 0, which implies that the company might have .

Chi Sheng Pharma & Biotech Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Chi Sheng Pharma & Biotech Co might have .

Chi Sheng Pharma & Biotech Co  (ROCO:4111) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Chi Sheng Pharma & Biotech Co Tariff Resilience Score Related Terms

ROCO:4111
84GF Score
Chi Sheng Pharma & Biotech Co Ltd ROCO:4111
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Chi Sheng Pharma & Biotech Co (ROCO:4111) Overvalued in 2026?

Based on GuruFocus' analysis, Chi Sheng Pharma & Biotech Co stock appears to be undervalued. The current stock price of NT$30.05 is trading 9.4% below its estimated GF Value™ of NT$33.16. GuruFocus considers Chi Sheng Pharma & Biotech Co to be Fairly Valued.

Key valuation signals for ROCO:4111:

  • Tariff Resilience Score: 0
  • GF Value™: NT$33.16 vs. price of NT$30.05 (9.4% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the ROCO:4111 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chi Sheng Pharma & Biotech Co Business Description

Address No. 3, Shijian Road, Hsin Chu Industrial Park, Hsinchu County, Hukou, TWN, 30316
Chi Sheng Pharma & Biotech Co Ltd manufactures and distributes medical medicines and equipment in Taiwan. It offers injections, including hemodialysis solutions, amino acid injections, vitamin injections, and externally applied medicines.
84GF Score

Get the complete analysis for ROCO:4111

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$30.05
Price
NT$33.16
GF Value